1530 related articles for article (PubMed ID: 32445273)
41. Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis.
Xie F; Xiong Y; Yan J; Wang L; Yan W
Bioengineered; 2022 Feb; 13(2):1963-1974. PubMed ID: 34787066
[TBL] [Abstract][Full Text] [Related]
42. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
Zhang W; Song C; Ren X
Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
[TBL] [Abstract][Full Text] [Related]
43. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer.
Hao J; Du X; Lv F; Shi Q
J Surg Res; 2021 Apr; 260():104-115. PubMed ID: 33333383
[TBL] [Abstract][Full Text] [Related]
44. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation.
Chen LY; Wang L; Ren YX; Pang Z; Liu Y; Sun XD; Tu J; Zhi Z; Qin Y; Sun LN; Li JM
Mol Cancer; 2020 Nov; 19(1):164. PubMed ID: 33225938
[TBL] [Abstract][Full Text] [Related]
45. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
Wang L; Hou S; Li J; Tian T; Hu R; Yu N
Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
[TBL] [Abstract][Full Text] [Related]
46. Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis.
Liu Y; Li H; Ye X; Ji A; Fu X; Wu H; Zeng X
World J Surg Oncol; 2020 Sep; 18(1):255. PubMed ID: 32993655
[TBL] [Abstract][Full Text] [Related]
47. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
48. Circ_0000043 promotes the proliferation, migration, invasiveness, and epithelial-mesenchymal transition in breast cancer cells via the miR-136-Smad3 axis.
Leng X; Huang G; Ding J; Ma F
Biochem Cell Biol; 2021 Jun; 99(3):277-285. PubMed ID: 33043682
[TBL] [Abstract][Full Text] [Related]
49. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
50. Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p.
Zhao Y; Ma X; Shi W
Mamm Genome; 2021 Dec; 32(6):517-529. PubMed ID: 34632534
[TBL] [Abstract][Full Text] [Related]
51. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
[TBL] [Abstract][Full Text] [Related]
52. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.
Yang C; Shi J; Wang J; Hao D; An J; Jiang J
Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997
[TBL] [Abstract][Full Text] [Related]
53. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
[TBL] [Abstract][Full Text] [Related]
54. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.
Wang L; Zhang Z; Tian H
J Clin Lab Anal; 2023 Jan; 37(1):e24781. PubMed ID: 36550019
[TBL] [Abstract][Full Text] [Related]
55. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
56. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
Li X; He J; Ren X; Zhao H; Zhao H
Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
[TBL] [Abstract][Full Text] [Related]
57. Circ_RPPH1 facilitates progression of breast cancer via miR-1296-5p/TRIM14 axis.
Jiang J; Shi S; Zhang W; Li C; Sun L; Ge Q; Li X
Cancer Biol Ther; 2024 Dec; 25(1):2360768. PubMed ID: 38816350
[No Abstract] [Full Text] [Related]
58. CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/HOXA11 pathway.
Wang H; Shan S; Wang H; Wang X
Anticancer Drugs; 2022 Jan; 33(1):e700-e710. PubMed ID: 34845164
[TBL] [Abstract][Full Text] [Related]
59. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
[TBL] [Abstract][Full Text] [Related]
60. Circ_0006528 Contributes to Paclitaxel Resistance of Breast Cancer Cells by Regulating miR-1299/CDK8 Axis.
Liu G; Zhang Z; Song Q; Guo Y; Bao P; Shui H
Onco Targets Ther; 2020; 13():9497-9511. PubMed ID: 33061434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
